{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:36Z","timestamp":1791409896176,"version":"4.3.3"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110263","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:21:41Z","timestamp":1784614901000},"page":"110263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-9216","authenticated-orcid":false,"given":"Nefisath","family":"Pandikatte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0531-8611","authenticated-orcid":false,"given":"Shashiprabha","family":"Sudhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9422-3958","authenticated-orcid":false,"given":"K.B.","family":"Vilas Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-5815","authenticated-orcid":false,"given":"Ramith","family":"Ramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0384-655X","authenticated-orcid":false,"given":"Ravindra R.","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6598-5355","authenticated-orcid":false,"given":"Chandan Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8650-2874","authenticated-orcid":false,"given":"Pran Kishore","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-1549","authenticated-orcid":false,"given":"Katharigatta N.","family":"Venugopala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1333-028X","authenticated-orcid":false,"given":"Jagadeesh Prasad","family":"Dasappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110263_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1568005013343272","article-title":"Molecular mechanisms of antibiotic resistance in gram-positive pathogens","volume":"1","author":"Dessen","year":"2001","journal-title":"Current Drug Targets - Infectious Disorders"},{"key":"10.1016\/j.bioorg.2026.110263_bb0010","doi-asserted-by":"crossref","unstructured":"K. Fridkin Scott, C. Hageman Jeffrey, M. Morrison, T. Sanza Laurie, K. Como-Sabetti, A. Jernigan John, K. Harriman, H. Harrison Lee, R. Lynfield, M. Farley Monica, Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352 (14) (2005) 1436\u20131444.","DOI":"10.1056\/NEJMoa043252"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110263_bb0015","first-page":"16","article-title":"On commensalism of Candida","volume":"6","author":"Romo","year":"2020","journal-title":"Journal of fungi (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2026.110263_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105327","article-title":"Design and synthesis of new drugs inhibitors of Candida albicans hyphae and biofilm formation by upregulating the expression of TUP1 transcription repressor gene","volume":"148","author":"Hamdy","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110263_bb0025","first-page":"87","article-title":"Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the hospital infection surveillance system)","volume":"108","author":"Geffers","year":"2011","journal-title":"Dtsch. Arztebl. Int."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0030","doi-asserted-by":"crossref","first-page":"ftw018","DOI":"10.1093\/femspd\/ftw018","article-title":"Pathogenesis of Candida albicans biofilm","volume":"74","author":"Tsui","year":"2016","journal-title":"Pathog Dis"},{"key":"10.1016\/j.bioorg.2026.110263_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101989","article-title":"Current advances in the clinical development of anti-tubercular agents","volume":"125","author":"Tetali","year":"2020","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110263_bb0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/1568026621999201211200447","article-title":"Tuberculosis: an update on pathophysiology, molecular mechanisms of drug resistance, newer anti-tb drugs, treatment regimens and host- directed therapies","volume":"21","author":"Borah","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110263_bb0045","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.pharep.2016.08.002","article-title":"Benzimidazole-core as an antimycobacterial agent","volume":"68","author":"Keri","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110263_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9050233","article-title":"Cytotoxicity and antimycobacterial properties of Pyrrolo[1,2-a]quinoline derivatives: molecular target identification and molecular docking studies","volume":"9","author":"Venugopala","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2026.110263_bb0055","first-page":"51","article-title":"Drug-resistant tuberculosis: emerging treatment options","volume":"3","author":"Adhvaryu","year":"2011","journal-title":"Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110263_bb0060","first-page":"547","article-title":"Tuberculosis in patients with acquired immune deficiency syndrome: the 75th annual meeting lunch-time seminar","volume":"75","author":"Nakata","year":"2000","journal-title":"Kekkaku(Tuberculosis)"},{"issue":"5639","key":"10.1016\/j.bioorg.2026.110263_bb0065","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1126\/science.1086845","article-title":"Antiretroviral drugs for tuberculosis control in the era of HIV\/AIDS","volume":"301","author":"Williams","year":"2003","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110263_bb0070","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/AAC.49.6.2153-2163.2005","article-title":"New small-molecule synthetic antimycobacterials","volume":"49","author":"Ballell","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"26","key":"10.1016\/j.bioorg.2026.110263_bb0075","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/1381612043383223","article-title":"Identification and validation of novel drug targets in tuberculosis","volume":"10","author":"Duncan","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110263_bb0080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMp1314385","article-title":"FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis","volume":"371","author":"Cox","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110263_bb0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.3823","article-title":"Timing is everything for compassionate use of delamanid","volume":"21","author":"Barry","year":"2015","journal-title":"Nat. Med."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110263_bb0090","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s40265-019-01207-9","article-title":"Pretomanid: first approval","volume":"79","author":"Keam","year":"2019","journal-title":"Drugs"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110263_bb0095","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.2174\/092986708785133013","article-title":"Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes","volume":"15","author":"Santanu","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110263_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/138955706775197839","article-title":"Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures","volume":"6","author":"Ahmed","year":"2006","journal-title":"Mini-Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110263_bb0105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bmcl.2007.08.078","article-title":"Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation","volume":"18","author":"Thimmegowda","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110263_bb0110","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1016\/j.bmc.2004.07.056","article-title":"Dicationic biphenyl benzimidazole derivatives as antiprotozoal agents","volume":"12","author":"Ismail","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110263_bb0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0960-894X(00)00619-3","article-title":"Synthesis and antiparasitic activity of 2-(trifluoromethyl)benzimidazole derivatives","volume":"11","author":"Navarrete-V\u00e1zquez","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110263_bb0120","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.bmcl.2008.05.009","article-title":"Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids","volume":"18","author":"Torres-G\u00f3mez","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110263_bb0125","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.ejmech.2010.01.067","article-title":"Synthesis and pharmacological evaluation of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives as anti-inflammatory and analgesic agents","volume":"45","author":"Gaba","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110263_bb0130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejmech.2014.06.060","article-title":"Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties","volume":"83","author":"Yoon","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110263_bb0135","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.ejmech.2009.05.021","article-title":"Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles","volume":"44","author":"Shingalapur","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110263_bb0140","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1016\/j.bmcl.2006.08.117","article-title":"Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands","volume":"16","author":"Lee-Dutra","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110263_bb0145","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/10111377","article-title":"Synthesis and potent antimicrobial activity of some novel N-(alkyl)-2-phenyl-1H-Benzimidazole-5-carboxamidines","author":"G\u00f6ker","year":"2005","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110263_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bioorg.2016.05.006","article-title":"Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents","volume":"67","author":"Eissa","year":"2016","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110263_bb0155","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/00397911.2019.1597125","article-title":"Design, synthesis and biological evaluation of substituted 2-amino-1,3-thiazine derivatives as antituberculosis and anti-cancer agents","volume":"49","author":"Nagendra Prasad","year":"2019","journal-title":"Synth. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110263_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jhet.3759","article-title":"Synthesis, reactions, and antimicrobial evaluations of new benzo[e][1,3]thiazine derivatives","volume":"57","author":"Ewies","year":"2020","journal-title":"J. Heterocyclic Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110263_bb0165","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00044-018-2222-9","article-title":"Synthesis and biological evaluation of coumarin clubbed thiazines scaffolds as antimicrobial and antioxidant","volume":"27","author":"Chauhan","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110263_bb0170","series-title":"Third-Generation Cephalosporins","author":"Arumugham","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110263_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127036","article-title":"Synthesis, crystal structure, antioxidant activity and DFT study of 2-aryl-2,3-dihydro-4H-[1,3]thiazino[3,2-a]benzimidazol-4-one","volume":"1199","author":"Ramos Rodr\u00edguez","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ardp.201000252","article-title":"Novel Benzimidazo[2,1-c][1,4]thiazinone derivatives with potent activity against HSV-1","volume":"344","author":"Galal","year":"2011","journal-title":"Arch. Pharm."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110263_bb0185","first-page":"1155","article-title":"A convenient one-pot synthesis of novel benzimidazole\u2013thiazinone derivatives and their antimicrobial activity","volume":"13","author":"Samreen","year":"2024","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110263_bb0190","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/10426507.2015.1135149","article-title":"Synthesis, spectral characterization, and antituberculosis activity of thiazino[3,2-a]benzimidazole derivatives","volume":"191","author":"Gong","year":"2016","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s42250-019-00084-9","article-title":"A review on the preparation of 1,3,4-oxadiazoles from the dehydration of Hydrazines and study of their biological roles","volume":"2","author":"Nayak","year":"2019","journal-title":"Chem. Afr."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110263_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13065-025-01698-6","article-title":"Design, synthesis, structural characterization, and antioxidant potential of novel triazole- and oxadiazole-based hydrazide-hydrazone derivatives: spectroscopic, DFT, and molecular docking studies","volume":"20","author":"Abdo","year":"2025","journal-title":"BMC Chemistry"},{"key":"10.1016\/j.bioorg.2026.110263_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109935","article-title":"Novel 1,2,3-thiadiazole-based hydrazone and 1,3,4-oxadiazole hybrids as promising agents against Streptococcus mutans: synthesis, biological evaluation, and molecular modeling studies","volume":"177","author":"Kurtulu\u015f","year":"2026","journal-title":"Bioorg. Chem."},{"issue":"32","key":"10.1016\/j.bioorg.2026.110263_bb0210","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2174\/0113816128361524250131110036","article-title":"Biological evaluation and computational modelling studies on N-acyl hydrazone and 2,5-disubstituted 1,3,4-oxadiazole derivatives as non-toxic antimicrobial agents","volume":"31","author":"Giray","year":"2025","journal-title":"Curr. Pharm. Des."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110263_bb0215","doi-asserted-by":"crossref","first-page":"15295","DOI":"10.3390\/ijms232315295","article-title":"Synthesis, biological evaluation and computational studies of new hydrazide derivatives containing 1,3,4-oxadiazole as antitubercular agents","volume":"23","author":"Zampieri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0220","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bmc.2007.11.014","article-title":"Design, synthesis and evaluation of Antiinflammatory, analgesic and Ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives","volume":"16","author":"Bhandari","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110263_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27217309","article-title":"Cytotoxic activity and docking studies of 2-arenoxybenzaldehyde N-acyl hydrazone and 1,3,4-oxadiazole derivatives against various cancer cell lines","volume":"27","author":"Ayd\u0131n","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110263_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144466","article-title":"Microwave-assisted synthesis, biological evaluation, and computational insights of novel S-substituted 5-(2-(phenylthio)pyridine-3-yl)-1,3,4-oxadiazole-2-thiol derivatives as multitarget antitubercular, antioxidant, antiprotozoal and antimicrobial agents","volume":"1352","author":"Mulla","year":"2026","journal-title":"J. Mol. Struct."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110263_bb0235","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1039\/D5RA00499C","article-title":"Repurposing the phenylthiazole scaffold with 1,3,4-oxadiazole for selective, potent and well-tolerated antifungal activity","volume":"15","author":"Hagras","year":"2025","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110263_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2021.101284","article-title":"1,3,4-oxadiazole-containing hybrids as potential anticancer agents: recent developments, mechanism of action and structure-activity relationships","volume":"25","author":"Nayak","year":"2021","journal-title":"J. Saudi Chem. Soc."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110263_bb0245","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/pr12061055","article-title":"Novel hydrazide hydrazone derivatives as antimicrobial agents: design, synthesis, and molecular dynamics","volume":"12","author":"Agili","year":"2024","journal-title":"Processes"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110263_bb0250","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","article-title":"Biological activities of hydrazone derivatives","volume":"12","author":"Rollas","year":"2007","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0255","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acs.cgd.5c00948","article-title":"Investigation of polymorphism in 2-Amino-4, 5-dimethylthiophene-3-carbonitrile","volume":"26","author":"Menon","year":"2026","journal-title":"Cryst. Growth Des."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0260","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/cg901565q","article-title":"A device to crystallize organic solids: structure of ciprofloxacin, midazolam, and ofloxacin as targets","volume":"10","author":"Mahapatra","year":"2010","journal-title":"Cryst. Growth Des."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110263_bb0265","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/cbdd.12736","article-title":"Synthesis, polymorphism, and insecticidal activity of methyl 4-(4-chlorophenyl)-8-iodo-2-methyl-6-oxo-1, 6-dihydro-4H-pyrimido [2, 1-b] quinazoline-3-carboxylate against Anopheles arabiensis mosquito","volume":"88","author":"Venugopala","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0270","first-page":"681","article-title":"Polymorphism in two biologically active dihydropyrimidinium hydrochloride derivatives: quantitative inputs towards the energetics associated with crystal packing","volume":"70","author":"Venugopala","year":"2014","journal-title":"Structural Science"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110263_bb0275","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/cg049948l","article-title":"Concomitant polymorphism in 3-Acetylcoumarin: role of weak C\u2212 H\u2299\u2299\u2299 O and C\u2212 H\u2299\u2299\u2299 \u03c0 interactions","volume":"4","author":"Munshi","year":"2004","journal-title":"Cryst. Growth Des."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110263_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202303188","article-title":"2,3,5-trisubstituted Thiazolidinone derivatives as potential antimicrobial and antitubercular agents and in silico studies","volume":"9","author":"Nefisath","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110263_bb0285","series-title":"Oxoimidazolidine derivatives as anti-tubercular agents","author":"Venugopala","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110263_bb0290","series-title":"(E)-2-(3-Cyano-4-isobutoxyphenyl)-N\u2032-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents","author":"Venugopala","year":"2024"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110263_bb0295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/antibiotics8040247","article-title":"Anti-tubercular activity of substituted 7-methyl and 7-formylindolizines and in silico study for prospective molecular target identification","volume":"8","author":"Venugopala","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2026.110263_bb0300","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/DDDT.S228381","article-title":"In silico design and synthesis of tetrahydropyrimidinones and tetrahydropyrimidinethiones as potential thymidylate kinase inhibitors exerting anti-TB activity against mycobacterium tuberculosis","author":"Venugopala","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2026.110263_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130305","article-title":"Synthesis, structural elucidation and larvicidal activity of novel arylhydrazones","volume":"1236","author":"P","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110263_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ph18121804","article-title":"Synthesis of novel arylhydrazones bearing 8-trifluoromethyl quinoline: crystal insights, larvicidal activity, ADMET predictions, and molecular docking studies","volume":"18","author":"Kotyan","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110263_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118425","article-title":"Targeting fungal biofilms: design, synthesis, biological and in silico studies of novel N-(5-undecyl-1,3,4-oxadiazol-2-yl)benzamide derivatives against Candida albicans","volume":"131","author":"Kumar","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110263_bb0320","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.archoralbio.2018.02.014","article-title":"In vitro investigation on probiotic, anti-Candida, and antibiofilm properties of lactobacillus pentosus strain LAP1","volume":"89","author":"Aarti","year":"2018","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.bioorg.2026.110263_bb0325","first-page":"564","article-title":"Antimicrobial compounds produced by vaginal lactobacillus crispatus are able to strongly inhibit Candida albicans growth, hyphal formation and regulate virulence-related gene expressions","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110263_bb0330","doi-asserted-by":"crossref","unstructured":"M.C.S. Louren\u00e7o, M.V.N.d. Souza, A.C. Pinheiro, M.d.L. Ferreira, R.S.B. Gon\u00e7alves, T.C.M. Nogueira, M.A. Peralta, Evaluation of anti-tubercular activity of nicotinic and isoniazid analogues, ARKIVOC 2007(15) (2007) 181\u2013191.","DOI":"10.3998\/ark.5550190.0008.f18"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110263_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150457","article-title":"Streptococcus mutans can modulate biofilm formation and attenuate the virulence of Candida albicans","volume":"11","author":"Barbosa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110263_bb0340","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fcimb.2020.00397","article-title":"The postbiotic activity of lactobacillus paracasei 28.4 against Candida auris","volume":"10","author":"Rossoni","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110263_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:11:46Z","timestamp":1791407506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":69,"alternative-id":["S0045206826007996"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110263","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110263"}}